Jazz Pharmaceuticals (JAZZ) PT Lowered to $202 at Piper Jaffray

February 27, 2019 3:01 AM EST Send to a Friend

Piper Jaffray analyst David Amsellem ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Jazz Pharmaceuticals (JAZZ) PT Lowered to $202 at Piper Jaffray

Member Login

Free News Feed